These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7460195)

  • 1. Adriamycin and daunomycin dose-dependent effects upon contractions of isolated rat myocytes.
    Lowe MC; Smallwood JI
    Cancer Chemother Pharmacol; 1980; 5(1):61-5. PubMed ID: 7460195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium protection against anthracycline toxicity in vitro.
    Zdanowicz MM; Barletta MA
    Magnes Res; 1991 Jun; 4(2):105-7. PubMed ID: 1911091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K; Perchellet JP
    Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart.
    Platel D; Bonoron-Adèle S; Robert J
    Pharmacol Toxicol; 2001 May; 88(5):250-4. PubMed ID: 11393585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional effects of adriamycin on cardiac cells in vitro.
    Lampidis TJ; Henderson IC; Israel M; Canellos GP
    Cancer Res; 1980 Nov; 40(11):3901-9. PubMed ID: 7471041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro.
    Dorr RT; Shipp NG; Lee KM
    Anticancer Drugs; 1991 Feb; 2(1):27-33. PubMed ID: 1958848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
    Singh Y; Ulrich L; Katz D; Bowen P; Krishna G
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):9-23. PubMed ID: 2763305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
    Taylor AL; Applefeld MM; Wiernik PH; Grochow LB; Mader LC; Bulkley BH
    Cancer; 1984 Apr; 53(8):1660-6. PubMed ID: 6582997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunomycin inhibits the uptake of adenine, amino acids, and glucose into cardiac myocytes.
    Reese JB; Shirhatti V; Singh Y; Krishna G
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):105-12. PubMed ID: 3564026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of adriamycin and daunomycin on myocardial cells cultured in vitro].
    Necco A; Dasdia T
    G Ital Chemioter; 1975; 22(1-2):15-8. PubMed ID: 1235346
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of mouse skin tumor promotion by adriamycin and daunomycin in combination with verapamil or palmitoylcarnitine.
    Satyamoorthy K; Perchellet JP
    Cancer Lett; 1990 Dec; 55(2):135-42. PubMed ID: 2265412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
    Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V
    Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios.
    Dorr RT; Bozak KA; Shipp NG; Hendrix M; Alberts DS; Ahmann F
    Cancer Res; 1988 Sep; 48(18):5222-7. PubMed ID: 3409247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEM observations on the effect of anthracycline drugs on cultured newborn rat cardiomyocytes.
    Djaldetti M; Gilgal R; Shainberg A; Klein B; Zahavi I
    Basic Res Cardiol; 1988; 83(6):672-7. PubMed ID: 3223881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.
    Dorr RT; Shipp NG; Liddil JD; Iyengar BS; Kunz KR; Remers WA
    Cancer Chemother Pharmacol; 1992; 31(1):1-5. PubMed ID: 1458553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
    Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V
    Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.